insights_auto
Why is RCEL up 4.26%?
Dive Deeperchevron_right
RCEL:NASDAQ
AVITA Medical Inc
$13.70
arrow_upward
+4.26%(+0.56) 1D
Oct 20, 10:53:41 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCEL...
Open
$13.29
High
$13.84
Low
$13.29
Mkt. cap
423.70M
Avg. vol.
321.85K
Volume
50.67K
52-wk high
$13.84
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
Open
$13.29
High
$13.84
Low
$13.29
Mkt. cap
423.70M
Avg. vol.
321.85K
Volume
50.67K
52-wk high
$13.84
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
ChartMill
·
19 minutes ago
S&P 500 Gap-Down Stocks Fall in October 20, 2026 Session
TradingView
·
1 hour ago
Chip Stocks Resume Declines
Yahoo Finance
·
1 hour ago
DOW Gains on Projects & Self-Help Actions Amid Demand and Cost Woes
The Motley Fool
·
5 hours ago
IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com